Skip to main content
MedPathMedPath Home
Clinical Trials/NCT03487094
NCT03487094
Completed
Not Applicable

Growth Monitoring Study of Infants Fed Formula for 16 Weeks

Nature's One23 sites in 1 country216 target enrollmentJuly 18, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChild Development

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Child Development
Sponsor
Nature's One
Enrollment
216
Locations
23
Primary Endpoint
Growth
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Growth and Tolerance Trial of Iron-fortified infant formulas

Detailed Description

16 WEEK GROWTH AND TOLERANCE

Registry
clinicaltrials.gov
Start Date
July 18, 2018
End Date
July 9, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Nature's One
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Healthy term infants, 37-42 weeks gestational age

Exclusion Criteria

  • •Any condition that would negatively impact assessment of growth and tolerance

Outcomes

Primary Outcomes

Growth

Time Frame: 16 weeks

Weight Gain

Study Sites (23)

Loading locations...

Similar Trials

Completed
Not Applicable
Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant FormulasInfant Development
NCT05947084Aussie Bubs, Inc.518
Terminated
Not Applicable
Growth and Tolerance Trial on Infant Formula With HMOHealthy Growth
NCT04066413FrieslandCampina265
Completed
Not Applicable
Growth and Tolerance of Infants Fed Infant FormulasGrowth and Tolerance
NCT01808105Abbott Nutrition424
Completed
Not Applicable
Study of Nutritional Suitability of a New Infant Formula for Term InfantsGrowth
NCT02490852Ausnutria Hyproca B.V.304
Completed
Not Applicable
Growth of Infants Fed a New Term Infant FormulaHealthy
NCT03090360Société des Produits Nestlé (SPN)349